SCHEMBL18947639

SCHEMBL18947639

Cc1ccc(C(=O)Nc2ccc(F)c(Cl)c2)cc1S(=O)(=O)NCCO

nearest known ligand 0.58

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 9/20 0.58
▸ TP53 P04637 6/20 0.58
▸ IDH1 O75874 3/20 0.55
▸ LMNA P02545 6/20 0.51
▸ SMN1; SMN2 Q16637 2/20 0.49
▸ NPC1 O15118 2/20 0.49
▸ RAB9A P51151 2/20 0.49
▸ GSTO1 P78417 1/20 0.49
▸ RECQL P46063 1/20 0.48
▸ CNR2 P34972 2/20 0.48
▸ MEN1 O00255 1/20 0.48
▸ ALDH1A1 P00352 1/20 0.48
▸ MAPK1 P28482 1/20 0.48
▸ HTT P42858 1/20 0.48
▸ KMT2A Q03164 1/20 0.48
▸ L3MBTL1 Q9Y468 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15076818 0.91 MAPT (0.57) MAPTTP53LMNASMN1; SMN2NPC1
SCHEMBL18947632 0.82 GSTO1 (0.53) MAPTTP53IDH1LMNASMN1; SMN2
SCHEMBL19157049 0.82 GSTO1 (0.57) MAPTTP53LMNASMN1; SMN2NPC1
SCHEMBL15076406 0.77 NPC1 (0.60) MAPTTP53LMNANPC1RAB9A
SCHEMBL18085479 0.77 CNR2 (0.80) MAPTTP53LMNASMN1; SMN2NPC1
SCHEMBL21623085 0.77 MAPT (0.57) MAPTTP53LMNASMN1; SMN2RAB9A
SCHEMBL15076699 0.77 GSTO1 (0.55) MAPTTP53LMNASMN1; SMN2NPC1
SCHEMBL15076807 0.76 NPC1 (0.59) MAPTTP53LMNASMN1; SMN2NPC1
SCHEMBL15076561 0.76 NPC1 (0.62) MAPTTP53LMNANPC1RAB9A
SCHEMBL15076741 0.76 GSTO1 (0.63) MAPTTP53LMNASMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9676747-B2 Hepatitis B antiviral agents NOVIRA THERAPEUTICS, INC. (US) 2017-06-13 — — US disclosed
Send feedback